This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Tanacetum parthenium
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
This herb may interact with medications you are taking. Review the interactions table below and consult your healthcare provider before use.
Feverfew is a flowering plant of the daisy family, native to Eurasia but now found worldwide. It has been used since ancient Greek times, primarily for headaches and fever. Modern research has focused on its use for migraine prevention, where it has shown promising results in clinical trials.
Feverfew is a flowering plant of the daisy family, native to Eurasia but now found worldwide. It has been used since ancient Greek times, primarily for headaches and fever. Modern research has focused on its use for migraine prevention, where it has shown promising results in clinical trials. Key active compounds include Parthenolide, Tanetin, Santamarin.
Parthenolide, along with Tanetin and Santamarin, are the primary bioactive compounds in Feverfew. These compounds acts on pain pathways via anti-inflammatory and neuroactive effects.
Migraine prevention
Supported by clinical evidence; more large-scale trials would strengthen findings
Headache treatment
Supported by clinical evidence; more large-scale trials would strengthen findings
Rheumatoid arthritis
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Fever reduction
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Menstrual pain management
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Arthritis relief
Based on traditional use; clinical evidence limited
Menstrual pain
Based on traditional use; clinical evidence limited
Anti-inflammatory
Based on traditional use; clinical evidence limited
| Drug | Severity | Description |
|---|---|---|
| NSAIDs (Ibuprofen) | Mild | Feverfew may have additive antiplatelet effects with NSAIDs, potentially increasing bleeding risk. |
| Warfarin (Coumadin) | Moderate | Feverfew may increase bleeding risk when combined with warfarin due to antiplatelet effects. |
Found an error or have a correction for Feverfew?
Report an Issue →